Mammographic density phenotypes and risk of breast cancer: A meta-analysis

Journal of the National Cancer Institute

Volumn 106, Issue 5, 2014, Pages

  Pettersson, Andreas ^a   Graff, Rebecca E ^a   Ursin, Giske ^b,c   Dos Santos Silva, Isabel ^d   McCormack, Valerie ^e   Baglietto, Laura ^f,g   Vachon, Celine ^h   Bakker, Marije F ^j,k   Giles, Graham G ^f,g,l   Chia, Kee Seng ^m   Czene, Kamila ^o,p   Eriksson, Louise ^o,p   Hall, Per ^o,p   Hartman, Mikael ^m,n,o,p   Warren, Ruth M L ^q   Hislop, Greg ^r   Chiarelli, Anna M ^s   Hopper, John L ^g   Krishnan, Kavitha ^f,g   Li, Jingmei ^t   Li, Qing ^u   Pagano, Ian ^v   Rosner, Bernard A ^a,w   Wong, Chia Siong ^m   Scott, Christopher ⁱ   Stone, Jennifer ^g   Maskarinec, Gertraud ^v   Boyd, Norman F ^u   Van Gils, Carla H ^j,k   Tamimi, Rulla M ^a,w   more..

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^f CANCER EPIDEMIOLOGY CENTRE   (Australia)

^g UNIVERSITY OF MELBOURNE   (Australia)

^h Division of Epidemiology   (Australia)

ⁱ Division of Biomedical Statistics and Informatics   (Australia)

^j MAYO CLINIC   (United States)

^k UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^l MONASH UNIVERSITY   (Australia)

^m NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

ⁿ NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^o NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^p KAROLINSKA INSTITUTE   (Sweden)

^q ADDENBROOKE S HOSPITAL   (United Kingdom)

^r UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^s CANCER CARE ONTARIO   (Canada)

^t GENOME INSTITUTE OF SINGAPORE   (Singapore)

^u PRINCESS MARGARET HOSPITAL   (Canada)

^v UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^w CHANNING LABORATORY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; BODY MASS; BREAST CANCER; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; DENSITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; META ANALYSIS; PARITY; PHENOTYPE; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW; BREAST; BREAST TUMOR; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY;

BREAST; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PHENOTYPE; POSTMENOPAUSE;

EID: 84905185461     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/dju078     Document Type: Review

References (38)

1. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2006;15(6):1159-1169.
2. Trichopoulos D, Lipman RD. Mammary gland mass and breast cancer risk. Epidemiology. 1992;3(6):523-526.
3. Kato I, Beinart C, Bleich A, Su S, Kim M, Toniolo PG. A nested case-control study of mammographic patterns, breast volume, and breast cancer. Cancer Causes Control. 1995;6(5):431-438.
4. Boyd N, Martin L, Gunasekara A, et al. Mammographic density and breast cancer risk: evaluation of a novel method of measuring breast tissue volumes. Cancer Epidemiol Biomarkers Prev. 2009;18(6):1754-1762.
5. Lokate M, Peeters PH, Peelen LM, Haars G, Veldhuis WB, van Gils CH. Mammographic density and breast cancer risk: the role of the fat surrounding the fibroglandular tissue. Breast Cancer Res. 2011;13(5):R103.
6. Pettersson A, Hankinson SE, Willett WC, Lagiou P, Trichopoulos D, Tamimi RM. Nondense mammographic area and risk of breast cancer. Breast Cancer Res. 2011;13(5):R100.
7. Vachon CM, Scott CG, Fasching PA, et al. Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammo-graphic density measures that predict breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2012;21(7):1156-1166.
8. Baglietto L, Krishnan K, Stone J, et al. Associations of mammographic dense and nondense areas and body mass index with risk of breast cancer. Am J Epidemiol. 2014;179(4):475-483.
9. Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med. 2007;356(3):227-236.
10. Maskarinec G, Pagano I, Lurie G, Wilkens LR, Kolonel LN. Mammographic density and breast cancer risk: the multiethnic cohort study. Am J Epidemiol. 2005;162(8):743-752.
11. Olson JE, Sellers TA, Scott CG, et al. The influence of mammogram acquisition on the mammographic density and breast cancer association in the Mayo Mammography Health Study cohort. Breast Cancer Res. 2012;14(6):R147.
12. Pinto Pereira SM, McCormack VA, Hipwell JH, et al. Localized fibrog-landular tissue as a predictor of future tumor location within the breast. Cancer Epidemiol Biomarkers Prev. 2011;20(8):1718-1725.
13. Stone J, Ding J, Warren RM, Duffy SW, Hopper JL. Using mammographic density to predict breast cancer risk: dense area or percentage dense area. Breast Cancer Res. 2010;12(6):R97.
14. Tamimi RM, Eriksson L, Lagiou P, et al. Birth weight and mammo-graphic density among postmenopausal women in Sweden. Int J Cancer. 2010;126(4):985-991.
15. Ursin G, Ma H, Wu AH, et al. Mammographic density and breast cancer in three ethnic groups. Cancer Epidemiol Biomarkers Prev. 2003;12(4):332-338.
16. Vachon CM, Brandt KR, Ghosh K, et al. Mammographic breast density as a general marker of breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2007;16(1):43-49.
17. Wong CS, Lim GH, Gao F, et al. Mammographic density and its interaction with other breast cancer risk factors in an Asian population. Br J Cancer. 2011;104(5):871-874.
18. Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ. The quantitative analysis of mammographic densities. Phys Med Biol. 1994;39(10):1629-1638.
19. Ursin G, Astrahan MA, Salane M, et al. The detection of changes in mam-mographic densities. Cancer Epidemiol Biomarkers Prev. 1998;7(1):43-47.
20. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188.
21. Higgins J P, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539-1558.
22. Higgins J P, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-560.
23. Bax L, Yu LM, Ikeda N, Moons KG. A systematic comparison of software dedicated to meta-analysis of causal studies. BMC Med Res Methodol. 2007;7(40).
24. Bax L, Yu LM, Ikeda N, Tsuruta H, Moons KG. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol. 2006;6(50).
25. Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371(9612):569-578.
26. Boyd NF, Martin LJ, Sun L, et al. Body size, mammographic density, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2006;15(11):2086-2092.
27. Harris HR, Tamimi RM, Willett WC, Hankinson SE, Michels KB. Body size across the life course, mammographic density, and risk of breast cancer. Am J Epidemiol. 2011;174(8):909-918.
28. Shepherd JA, Kerlikowske K, Ma L, et al. Volume of mammographic density and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2011;20(7):1473-1482.
29. Heine JJ, Cao K, Rollison DE, Tiffenberg G, Thomas JA. A quantitative description of the percentage of breast density measurement using full-field digital mammography. Acad Radiol. 2011;18(5):556-564.
30. Boyd NF, Martin LJ, Bronskill M, Yaffe MJ, Duric N, Minkin S. Breast tissue composition and susceptibility to breast cancer. J Natl Cancer Inst. 2010;102(16):1224-1237.
31. Brower V. Homing in on mechanisms linking breast density to breast cancer risk. J Natl Cancer Inst. 2010;102(12):843-845.
32. Butcher DT, Alliston T, Weaver VM. A tense situation: forcing tumour progression. Nat Rev Cancer. 2009;9(2):108-122.
33. Provenzano PP, Inman DR, Eliceiri KW, Keely PJ. Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK-ERK linkage. Oncogene. 2009;28(49):4326-4343.
34. Pettersson A, Tamimi RM. Breast fat and breast cancer. Breast Cancer Res Treat. 2012;135(1):321-323.
35. McInnes KJ, Brown KA, Knower KC, Chand AL, Clyne CD, Simpson ER. Characterisation of aromatase expression in the human adipocyte cell line SGBS. Breast Cancer Res Treat. 2008;112(3):429-435.
36. Simpson ER, Clyne C, Rubin G, et al. Aromatase-a brief overview. Annu Rev Physiol. 2002;64:93-127.
37. Beer AE, Billingham RE. Adipose tissue, a neglected factor in aetiology of breast cancer? Lancet. 1978;2(8084):296.
38. Ghosh K, Hartmann LC, Reynolds C, et al. Association between mam-mographic density and age-related lobular involution of the breast. J Clin Oncol. 2010;28(13):2207-2212.